United Kingdom signs an agreement with Pfizer to secure 35 million doses of the Pfizer-BioNTech COVID-19 vaccine due to be delivered in the second half of 2022
The United Kingdom signs an agreement with Pfizer to secure 35 million doses of the Pfizer-BioNTech COVID-19 vaccine due to be delivered in the second half of 2022 as the government focuses on a "future-proof vaccine programme" to prevent any virus variants that are resistant to the vaccine.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthUnited Kingdom signs an agreement with Pfizer to secure 35 million doses of the Pfizer-BioNTech COVID-19 vaccine due to be delivered in the second half of 2022
View Premium plansBrowse free archive reportsThe United Kingdom signs an agreement with Pfizer to secure 35 million doses of the Pfizer-BioNTech COVID-19 vaccine due to be delivered in the second half of 2022 as the government focuses on a "future-proof vaccine programme" to prevent any virus variants that are resistant to the vaccine.